£50m NHS cancer drug fund branded 'unfair'

A £50 million NHS fund for cancer drugs deemed too expensive by NICE may be unfair and could run out of cash, a GP prescribing expert has warned.

NICE: over-ruled by DoH fudn (Photograph: Jason Heath Lancy)
NICE: over-ruled by DoH fudn (Photograph: Jason Heath Lancy)

The fund was launched last week under DoH plans to improve use of new treatments.

But Dr Bill Beeby, GPC prescribing subcommittee chairman, questioned whether it was right to over-rule NICE's decisions on cost effectiveness.

'Is it fair to have an organisation called NICE, which is meant to make that assessment, and then find pressure on the government leads to a special fund for some people?' he said.

The launch came as a report by England's cancer director Professor Sir Mike Richards showed UK use of new cancer drugs lags behind most of Europe.

Sir Mike said the Cancer Drug Fund, launching in April 2011 but starting in interim form from October in England, would help 'several thousand' patients.

But Dr Beeby said it only 'scratched the surface'. 'Cancer drugs can cost £50,000 or more. When you start dividing £50 million by those sorts of figures, it doesn't go far.'

The Alzheimer's Society said Sir Mike's report was a 'scathing indictment of problems with access to dementia drugs' after it ranked the UK 11th out of 14 countries.

Asked why there was no new fund for other disease areas, the DoH said: 'There are some innovative new cancer treatments NICE cannot approve due to cost-effectiveness.

In the long term, the government plans to introduce value-based pricing and make new medicines available to NHS patients.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Former Brexit secretary backs vitamin D supplements to beat COVID-19

Former Brexit secretary backs vitamin D supplements to beat COVID-19

The NHS should provide 10 times the current daily recommended amount of vitamin D...

Identifying patients experiencing domestic violence and abuse in general practice

Identifying patients experiencing domestic violence and abuse in general practice

Dr Vasumathy Sivarajasingam describes a pilot project in her practice that used a...

Long COVID could ‘wreak havoc’ on NHS workforce and disrupt vaccine rollout

Long COVID could ‘wreak havoc’ on NHS workforce and disrupt vaccine rollout

High rates of COVID-19 infection and the impact of long COVID could 'wreak havoc'...

GPs can give COVID and flu jabs at same time, says NHS England

GPs can give COVID and flu jabs at same time, says NHS England

GPs can now administer COVID-19 and flu jabs at the same time, according to updated...

Areas hit hardest by COVID-19 fall behind on vaccine campaign

Areas hit hardest by COVID-19 fall behind on vaccine campaign

Regions of England hit hardest by COVID-19 cases have fallen behind the rest of the...

COVID-19 pandemic drives first recorded dip in patients registered with GPs

COVID-19 pandemic drives first recorded dip in patients registered with GPs

A rise in deaths and reduced immigration during the COVID-19 pandemic saw the first-ever...